Labcorp Drug Development

Clear and confident health care decisions begin with questions. At Labcorp, were constantly in pursuit of answers. With unparalleled diagnostics and drug development capabilities, we accelerate innovation and provide insight to improve health and improve lives. Whether youre a patient, provider, researcher or in the pharmaceutical industry, were here for you. More than 70,000 employees strong, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $14 billion in FY 2020. Learn more at www.Labcorp.com

Drug development services ,toxicology services,central labs,central laboratory services ,clinical trial management ,cro ,research,life sciences,clinical research,phase i-iia,phase ii-iiib,preclinical solutions,oncology,market access,rare disease ,orphan drugs ,biotech,pharma,pharmaceuticals,crop protection,clinical trial optimization,clinical trials,cell and gene therapy,nash,pharmacovigilance,patient support,patient safety,infectious diseases,immuno oncology,commercialization,pediatrics,kidney disease,inflammation,bioassays,bioanalysis ,large molecule ,small molecule,clinical trial informatics,preclinical services,and nonclinical services

Labcorp drug development operates in the Hospitals and health care industry.

Labcorp drug development's revenue is 501m - 1b

Labcorp drug development has 5001 - 10000 employees.